Malaria and safety issues associated with antimalarial drugs
Abstract
Malaria is one of the most challenging infectious diseases that poses a serious threat to the health and lives of patients around the world, including the Russian Federation. One of the main problems associated with the treatment of falciparum malaria is development of resistance to many drugs. A serious problem in Russia is a constant shortage of antimalarial drugs.
About the Authors
A. S. Kazakov
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
T. M. Bukatina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
N. Yu. Velts
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
M. A. Darmostukova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
E. O. Zhuravleva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
References
1. World Health Organization (WHO) [Internet]. 2017 (cited 2017May15). Available from: http://www.who.int.
2. Kovacs SD, Rijken MJ, Stergachis A. Treating Severe Malaria in Pregnancy: A Review of the Evidence. Drug Safety 2015; 38: 165–181.
3. Popov AF. Lechenie malyarii. Infectiology 2014; 6 (1): 5–12.
4. Tokmalaev AK. Malyariya: sovremennoe sostoyanie diagnostiki i lecheniya. Vestnik RUDN 2011; 3: 82–88.
5. Ivanova TN, Petrova GN, Timoshenko NI. Malyariologicheskaya situaciya v Moskve 2000–2004 gg. Medicinskaya parazitologiya i parazitarnye bolezni 2005; 4: 3–7.
6. Lysenko AYa, Kondrashin AV, Ezhov MN. Malyariologiya. VOZ; 2003.
7. Popov AF, Tokmalaev AK, Nikiforov ND. Malyariya. M.: RUDN; 2004.
8. Kondrashin AV. Mezhdunarodnyj kongress po ehliminacii malyarii. Medicinskaya parazitologiya i parazitarnye bolezni 2012; 3: 61–3.
9. Snegireva II, Zatolochina KE, Ozeretskovsky NA, Romanov BK, Mironov AN. Vaccine pharmacovigilance in Russia, legal and regulatory framework, current stage of development. Scientific Centre for Expert Evaluation of Medicinal Products Bulletin 2014; 4: 27–31.
Review
For citations:
Kazakov A.S., Bukatina T.M., Velts N.Yu., Darmostukova M.A., Zhuravleva E.O. Malaria and safety issues associated with antimalarial drugs. Safety and Risk of Pharmacotherapy. 2017;5(3):112-116. (In Russ.)
Views:
1221
Email this article 